Back to Search
GOMATHY SUBRAMANIAN, MD
MD
Internal Medicine Physician
NPI: 1922066182IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
25MA07977000(NJ)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 1998
Research & Publications (20)
Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
PMID 15289325·Cancer Res·2004
8-other
Risk factors for posterior compared to anterior ischemic stroke: an observational study of the Registry of the Canadian Stroke Network.
PMID 19299902·Neuroepidemiology·2009
4-observational
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C.
PMID 19061971·Clin Gastroenterol Hepatol·2009
3-trial
Raxibacumab for the treatment of inhalational anthrax.
PMID 19587338·N Engl J Med·2009
4-observational
Early prediction of sustained virological response at day 3 of treatment with albinterferon-alpha-2b in patients with genotype 2/3 chronic hepatitis C.
PMID 19291180·Liver Int·2009
8-other
Cathodic behaviour of stainless steel in coastal Indian seawater: calcareous deposits overwhelm biofilms.
PMID 19169951·Biofouling·2009
7-preclinical
An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.
PMID 19175870·J Viral Hepat·2009
3-trial
Fluorimetric determination of rivastigmine in rat plasma by a reverse phase--high performance liquid chromatographic method. Application to a pharmacokinetic study.
PMID 18589553·Arzneimittelforschung·2008
7-preclinical
Effect of docetaxel on the surgical tumor microenvironment of head and neck cancer in murine models.
PMID 18645124·Arch Otolaryngol Head Neck Surg·2008
7-preclinical
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C.
PMID 18666223·Hepatology·2008
3-trial
A study of rivastigmine liposomes for delivery into the brain through intranasal route.
PMID 19103565·Acta Pharm·2008
7-preclinical
Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.
PMID 18560223·Chemotherapy·2008
7-preclinical
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients.
PMID 18467185·Clin Gastroenterol Hepatol·2008
3-trial
Conformational properties of blends of cyclic and linear polymer melts.
PMID 18351867·Phys Rev E Stat Nonlin Soft Matter Phys·2008
8-other
On the relationship between two popular lattice models for polymer melts.
PMID 19045165·J Chem Phys·2008
8-other
Safety, pharmacokinetics, and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1-infected patients.
PMID 18266604·J Infect Dis·2008
3-trial
Clinical, laboratory and radiological parameters in children with dengue fever and predictive factors for dengue shock syndrome.
PMID 17965098·J Trop Pediatr·2008
8-other
Comparative analysis of cyanobacterial superoxide dismutases to discriminate canonical forms.
PMID 18042279·BMC Genomics·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 33 OVERLOOK RD, SUITE L06
SUMMIT, NJ 07901 - Phone
- (908) 522-0050
Quick Facts
- NPI
- 1922066182
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile